The strong Q1 sales growth, particularly in the core Tri-Shield product line, signals effective execution of the company's strategy; traders should monitor the upcoming May 15 conference call for full financial details and guidance, which could confirm momentum and drive further upside.
Price Chart
Executive Summary
ImmuCell reported a 28.4% year-over-year increase in preliminary, unaudited product sales for Q1 2026, reaching $10.4 million, driven by strong domestic and Tri-Shield First Defense sales growth, partially offset by a decline in international sales.
Key Financial Metrics
Key Facts
- Total product sales for Q1 2026 were $10.4 million, up 28.4% year-over-year from $8.1 million in Q1 2025
- Domestic sales grew 35.7% to $9.7 million, while international sales declined 30.2% to $0.6 million
- Tri-Shield First Defense sales increased 38.5% to $7.9 million, driving overall growth
- Dual-Force and other sales increased 4.4% to $2.5 million
- No EPS or net income data provided; release is preliminary and unaudited
Financial Impact
$2.3 million increase in total product sales (28.4% YoY growth)
Risk Factors
- International sales declined 30.2%, indicating potential challenges in that market
- Preliminary sales results are unaudited and subject to revision
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-011757 |
| Exhibit: ex_943323.htm | 0001437749-26-011757 |
| Document: 0001437749-26-011757-index-headers.html | 0001437749-26-011757 |
| Document: 0001437749-26-011757-index.html | 0001437749-26-011757 |
| Document: 0001437749-26-011757.txt | 0001437749-26-011757 |
| 8-K Data (Synthetic) | 0001437749-26-011757 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 8-K | $10.79 $10.45 | ▼ −3.15% | ▼ −2.00% | $10.24 (−5.10%) |
May 8, 2026 24w ago | 8-K | $8.45 $9.91 | ▲ +17.28% | ▲ +17.36% | $10.24 (+21.18%) |
Apr 8, 2026 28w ago | 8-K | $7.19 $7.54 | ▲ +4.87% | ▲ +1.68% | $10.24 (+42.42%) |
Apr 8, 2026 28w ago | Press Release | $7.19 $7.54 | ▲ +4.87% | ▲ +1.68% | $10.24 (+42.42%) |
Mar 4, 2026 33w ago | 8-K | $6.35 $6.63 | ▲ +4.41% | ▲ +6.65% | $10.24 (+61.26%) |
Mar 4, 2026 33w ago | Press Release | $6.35 $6.63 | ▲ +4.41% | ▲ +6.65% | $10.24 (+61.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers